Outcomes of Radiation Overlap and Margin Length in Intracoronary Brachytherapy for In-Stent Restenosis.

Background: In-stent restenosis (ISR) is a common complication following coronary stent implantation. Intracoronary brachytherapy (ICBT) has re-emerged as an effective treatment modality. However, optimal procedural strategies, including the role of radiation source overlap and adequate margin length, remain unclear.

Intravascular brachytherapy versus drug-coated balloons for in-stent restenosis: A two-center two-strategy comparison.

Background: In-stent restenosis remains a persistent challenge in interventional cardiology. While both intravascular brachytherapy (IVB) and drug-coated balloons (DCB) have been used to treat this condition, their comparative effectiveness has never been evaluated.

Objectives: To compare the efficacy and safety of IVB versus DCB for the treatment of in-stent restenosis.

Outcomes of intravascular brachytherapy for in-stent restenosis in small versus large coronary vessels.

Background: In-stent restenosis (ISR) remains a significant challenge in coronary intervention. Vessel size is recognized as an important predictor of outcomes following percutaneous coronary interventions, with smaller vessels traditionally associated with higher rates of restenosis. This study evaluates the clinical outcomes of vascular brachytherapy for ISR stratified by vessel size.

Transcatheter Management of Tricuspid Regurgitation: A Review of Contemporary Evidence.

Tricuspid regurgitation (TR) is a common valvular heart disease that is associated with increased morbidity and mortality. Traditional surgical interventions, though definitive, carry considerable complexities and risks, especially for high-risk patients, with in-hospital mortality rates of ˜9%. This resulted in the undertreatment of many patients with TR, creating a substantial unmet need.

Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials.

Background And Aims: Colchicine is an anti-inflammatory drug that may prevent post-operative atrial fibrillation (POAF). The effect of this drug has been inconsistently shown in previous clinical trials. We aimed to compare the efficacy and safety of colchicine vs.

Digoxin Use in Atrial Fibrillation; Insights From National Ambulatory Medical Care Survey.

The study evaluates the characteristics and trends of digoxin use during outpatient visits with atrial fibrillation in the US from 2006 to 2015.We conducted a retrospective analysis of adult (age >/= 18) patient visits to office-based physicians from National Ambulatory Medical Care Survey (NAMCS) database between 2006-2015. The International Classification of Diseases, Ninth Revision, Clinical Modification codes were used to identify patients with Atrial fibrillation.